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19F NMR spectroscopy monitors ligand binding
to recombinantly fluorine-labelled b’x from
human protein disulphide isomerase (hPDI)†
Rose Curtis-Marof, Denisa Doko, Michelle L. Rowe, Kirsty L. Richards,
Richard A. Williamson* and Mark J. Howard*
We report a protein-observe 19F NMR-based ligand titration
binding study of human PDI b’x with Δ-somatostatin that also
emphasises the need to optimise recombinant protein fluorination
when using 5- or 6-fluoroindole. This study highlights a recombi-
nant preference for 5-fluoroindole over 6-fluoroindole; most likely
due to the influence of fluorine atomic packing within the folded
protein structure. Fluorination affords a single 19F resonance probe
to follow displacement of the protein x-linker as ligand is titrated
and provides a dissociation constant of 23 ± 4 μM.
Protein disulphide isomerase (PDI) is a key enzyme respon-
sible for the formation of native disulphide bonds in proteins
that enter the secretory pathway of eukaryotic cells. PDI is a
multifunctional protein able to catalyse the oxidation and iso-
merisation of disulphide bonds, as well as to bind to unfolded
proteins and act as a molecular chaperone.1 The isomerisation
of incorrectly paired cysteine residues is often a rate-limiting
step on the folding pathway of disulphide bond-containing
proteins both in vitro and in vivo.2 The ability of PDI to
combine redox and molecular chaperone-like activities allows
it to bind to partly structured folding intermediates and to
catalyse simultaneously protein folding and associated native
disulphide bond formation.3 PDI is the archetype of a large
family of ER-resident PDI-like proteins.2
PDI contains four thioredoxin-like domains, two of which –
like thioredoxin itself – have redox-active catalytic sites (a and
a′) and two of which do not (b and b′). The domain order is
a-b-b′-x-a′-c, where x is a 19 residue linker between the b′ and a′
domains4,5 and c is a C-terminal acidic tail containing the
KDEL ER-retention signal. The a and a′ domains are respon-
sible for the redox activity of PDI while the b′ domain has been
shown to be essential for ligand binding.6 The b′ domain
binds both small and large peptide ligands, although large
ligands also require the a and a′ domains to contribute to the
overall binding interaction.6,7 The b′ domain has been shown
to contribute to the substrate specificity of PDI4,8 and is
required for disulphide isomerisation reactions in protein
substrates.9
The nature of substrate binding involving the b′ domain
continues to be a subject of interest and any information
regarding the role of b′ and x is extremely useful. Recent
studies have highlighted the b′ domain of human PDI (hPDI)
to be structurally connected and influenced by x, the linker
that connects the b′ and a′ domains. The b′x construct has
been shown to be receptive to ligand binding4 and x has also
been shown to moderate homodimerisation in b′x and bb′x.10
These data supported the previously published crystal struc-
ture studies of a b′x mutant that confirms b′ contains the
thioredoxin-fold with x occluding the ligand binding site as
mapped using NMR chemical shifts.4,11 As a result, it is
thought that b′x exists in two conformational states with the
x-linker ‘capping’ or ‘uncapping’ the ligand binding site and
that ‘uncapping’ provided opportunity for homodimerisa-
tion.4,10 Limited proteolysis, using wild-type and mutant pro-
teins to promote or retard ‘capping’, confirmed the x-linker
operates similarly in full-length hPDI.12 Homodimerisation in
hPDI is a mechanism by which the binding site is hidden
from substrates, and has been proposed as a potential regu-
lation mechanism for the protein in vivo.10
hPDI bb′x and bb′ have been studied using 1H, 15N-HSQC
chemical shift mapping to provide estimated dissociation
constants (Kd) with peptide ligands Δ-somatostatin
(AGSKNFFWKTFTSS) and mastoparan (INLKALAALAKKIL)4,8
with these studies approximating the Kd in the range of
0.1–1.0 mM. Despite these investigations, the role of the
x-linker remains a point of conjecture because backbone reson-
ances in the linker itself were notoriously difficult to observe
and track in the 1H, 15N-HSQC ligand binding studies men-
tioned above due to chemical shift line broadening. Therefore,
we present this concise study of x within b′x using 19F NMR
to follow the displacement of the ‘capped’ form of the linker
when a known peptide ligand is titrated against constant
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protein concentration. Switching to 19F NMR provides an
optimum detection window of the x-linker to observe both
ligand binding and displacement of the linker from the
binding site. This is facilitated by the fact that hPDI b′x con-
tains only a single tryptophan residue that resides at position
347 within the x-linker and positioned directly above the
reported ligand binding site as shown in Fig. 1. In addition,
we also describe the rationale behind our choice of indole
fluorination that provides optimal expression.
All NMR datasets were acquired at 298 K using a Bruker
Avance III 14.1 T (600 MHz 1H) NMR spectrometer equipped
with a 5 mm QCI-F cryoprobe. Data were processed using
Bruker Topspin 3.1 software and referenced using the position
of the 1H2O, relative gyromagnetic ratios (for
15N) or using tri-
fluoroacetic acid (for 19F). Bacterial expression and purifi-
cation of all proteins were identical to that reported previously
for hPDI b′x4,10 with additional steps only to permit fluorina-
tion in accordance with the recently published protocol by
Crowley and co-workers.13 For convenience, the entire growth
protocol and purification can be found in the ESI.† The
method utilises a standard bacteria minimal growth media
with 60 mg L−1 of indole, 5-fluoroindole or 6-fluoroindole
added 15 minutes prior to induction with IPTG (isopropyl β-D-
1-thiogalactopyranoside). All indoles were added to the growth
media from a 200× dimethylsulfoxide (DMSO) stock solutions.
An SDS-PAGE gel illustrating the effect of each indole on
expression of hPDI b′x is shown in Fig. 2.
The inclusion of indole using DMSO as a stock carrier
liquid did not hinder induction of the protein and the
addition of 5-fluoroindole did also not alter the protein yield.
From a minimal growth medium both indole and 5-fluoro-
indole provided yields of 6–8 mg L−1 of purified protein.
However, Fig. 2 highlights the effect of using 6-fluoroindole
where the yield of recombinant b′x was found to be consist-
ently lower than for indole and 5-fluoroindole with an esti-
mated yield of ca. 0.5 mg L−1.
Differences in fluoroindole overexpression are likely be
related to the positioning of the fluorine in the indole ring
and the SDS-PAGE gel in Fig. 2 highlights the importance of
utilising fluorination that supports correct folding of a stable
protein. This hypothesis was further corroborated using mass
spectrometry (Bruker MicroTOF-Q) where 5-F-Trp incorpor-
ation was found to be >80% but 6-F-Trp incorporation was ca.
55% (see ESI Fig. 2†) confirming that 6-F-Trp incorporation
was less successful. In an attempt to understand the effect of
fluorination, Fig. 3 uses the ‘capped’ b′x I272A structure with
in silico modified tryptophans to highlight the structural
effects of 5-fluoro- (5-F-Trp: Fig. 3a) or 6-fluorotryptophan
(6-F-Trp: Fig. 3b) labelling of b′x.
Close inspection of these structures suggests that when flu-
orine is present as 6-F-Trp, the fluorine is packed against resi-
dues F223, I284, F287 and F288 (see ESI Fig. 3a†). These four
residues were emphasised as providing key interactions
between b′ and the x-linker in the crystal structure.11 In con-
trast, inspection of the structure where fluorine is present
using 5-F-Trp confirms that this structure experiences fewer
critical interactions because the fluorine atom resides in a
pocket above the ligand-binding site (Fig. 3a and ESI Fig. 3b†).
The structural stability difference expected for 5-F-Trp versus
6-F-Trp is a likely explanation for the difference in expression
yields when using 5-fluoro- and 6-fluoroindole. It could be
Fig. 1 Crystal structure of hPDI b’x I272A with the ‘capped’ x-linker
shown in magenta and the ligand-binding site in yellow. Trp 347 is
shown in stick form. The sequence and secondary structure of b’x is
shown in ESI Fig. 1.† Fig. 2 15% SDS-PAGE of hPDI b’x showing samples taken pre- and
post-induction in minimal media without indole, with indole, with 5-
fluoroindole (5-F) and with 6-fluoroindole (6-F). Lane 1 shows Precision-
Plus protein standard markers labelled with molecular weight (kDa) and
the black arrow highlights the position of b’x.
Fig. 3 Structure of hPDI b’x’ I272A (3bj5.pdb) showing the x-linker
tryptophan modified in silico with fluorine inserted into the indole ring
as a green van der Waals sphere to represent 5-F labelling (a) and 6-F
labelling (b).
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suggested that 6-fluoroindole may have compromised cell
metabolism resulting in the loss of production. However,
observed growth rates were similar regardless of indole utilised
and close inspection of post-expression gel bands in Fig. 2
between 20–100 kDa supports comparable background protein
levels across all samples. This observation would support that
6-fluoroindole does not adversely affect tryptophan synthase
because many of these background proteins must also require
tryptophan. In addition, we can confirm from other studies
that 6-fluoroindole can be used to successfully produce other
proteins with 6-F-Trp (unpublished results). However, these
data do highlight the need to carefully consider the choice of
fluorination sites when producing labelled proteins. The struc-
tural integrity of wild-type b′x expressed in the presence and
absence of 5-F-Trp was assessed using 1H, 15N-HSQC data
obtained from samples grown in minimal media containing a
single nitrogen source of 0.6 mg L−1 U-15N ammonium sul-
phate. 1H, 15N-HSQC b′x and 5-F-Trp-b′x spectra are shown in
Fig. 4. The spectra overlay extremely well and suggest both
samples have the same fold and structural arrangement,
which is confirmed via a minimal chemical shift map analysis
of the data (ESI Fig. 4†). Furthermore, these data are also com-
parable to previously published 1H, 15N-HSQC spectra of wild-
type and x-linker ‘capping’ mutants of b′x.4,11
The degree of fluorination was estimated by comparing the
relative ratios of the indole NH peaks in the 1H, 15N-HSQC
spectra of b′x and 5-F-Trp-b′x and was found to vary between
80–90% depending on the preparation. This is in good agree-
ment with the mass spectrometry data shown in ESI Fig. 2.†
19F NMR spectra of 0.3 mM hPDI 5-F-Trp-b′x were obtained
with increasing Δ-somatostatin peptide concentration and are
shown in Fig. 5. Each 1D 19F NMR experiment was acquired
over 1024 scans using a relaxation delay of 2 s and an acqui-
sition time of 0.321 s. The data obtained in Fig. 5 demon-
strates the utility of the QCI-F cryoprobe and the ability to
create a dataset within half the time required to acquire a 1H,
15N-HSQC dataset. This is especially important because b′x is
prone to dimerise over time and the monomeric state in the
predominantly ‘capped’ x conformation is required for this
measurement. It is for this reason that a spectrum of a
48-hour ‘aged’ b′x sample is also shown in Fig. 5 where
both ‘capped’ and ‘uncapped’ forms can be distinguished by
19F NMR. Using a fresh, purified sample enabled the titration
of Δ-somatostatin to be monitored through a single 19F reso-
nance that reports on the x-linker status as the peak tracks
from the ‘capped’ toward the ‘uncapped’ state. It is interesting
to note the reduction in 19F resonance line width as ligand is
added; this supports the displacement of the x-linker in b′x as
ligand binds to the protein. Once the linker is displaced, it will
display increased mobility compared to the bulk protein,
which manifests as an increase in the 19F T2 relaxation time
and subsequent reduction in line width. This reduction in
linewidth associated with x-linker displacement has also been
observed in 1H, 15N HSQC spectra.4,11 The change in 19F
chemical shift with ligand concentration from Fig. 5 can be
plotted as shown in Fig. 6 and fitted using the well-documen-
ted equation below14,15 where Δ is the observed change in
chemical shift, Δo is the maximum shift and [L] and [P] are
ligand and protein concentration respectively.
Δ ¼ Δo
ðKd þ ½L þ ½PÞ 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ððKd þ ½L þ ½PÞ2  4½P½LÞ
q
2½P
Solving the equation to fit the curve in Fig. 6 produces a
dissociation constant for hPDI 5-F-Trp-b′x with Δ-somatostatin
of 23 ± 4 μM. This value is marginally lower than that obtained
from earlier studies that report Kd is in the 1.0–0.1 mM range
and suggests the affinity of 5-F-Trp-b′x for Δ-somatostatin is
higher than for the wild-type b′x protein. This likely to be due
to a small but significant destabilisation of ‘capped’ species
caused by fluorination that promotes displacement of the
x-linker and exposure of the binding site. Fluorine substitutions
Fig. 4 1H, 15N-HSQC spectra of hPDI b’x (a) and 5-F-Trp-b’x (b) from
0.25 mM protein samples. Data were acquired for each spectrum as
2048 × 256 points over 45 minutes.
Fig. 5 19F NMR spectra of 0.3 mM 5-F-Trp-b’x with increasing concen-
tration of Δ-somatostatin peptide (Δ-som). 19F NMR spectra of 48 h
‘aged’ 5-F-trp-b’x shows 19F resonances reporting on ‘capped’ and
‘uncapped’ x-linker and 5-fluoroindole are also shown.
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in proteins and peptides have been known to stabilise and
drive hydrophobic interactions and the ligand-binding process
across many PDIs including hPDI b′x is considered as hydro-
phobically driven.
If fluorine mediated hydrophobicity increased the strength
of binding of the x-linker region to b′ then one might expect
‘uncapping’ to be more unfavourable with the consequence
that ligand affinity is reduced. This does not appear to be
the case.
A third explanation could be that the ligand experiences
favourable hydrophobic interactions with the ‘uncapped’
x-linker; this would manifest as increased affinity and a lower
Kd. These observations suggest the smaller Kd is driven by
destabilisation of the ‘capped’ state and/or the ‘uncapped’
state experiences a hydrophobically driven binding event that
is stabilised by fluorination. The latter hypothesis proposes a
potential role for the x-linker in ligand binding and such a
process has been suggested from analysis of recent crystal
structures of yeast16 and hPDI17 as well as in silico modelling
and SAXS analysis of PDI from Humicola insolens.18,19
Conclusions
19F labelling using 5-fluoroindole to produce 5-fluorotrypto-
phan for protein NMR spectroscopy is straightforward and suc-
cessful. In addition, 5-fluoro-L-tryptophan is approximately
50-times more expensive than 5-fluoroindole per gram, thus
making fluoroindole-based labelling economical. However, our
experience draws attention to the care required to find the
optimum fluoroindole for the system to be studied. hPDI b′x
was best served using 5-fluoroindole but it is worth noting that
4-fluoro-, 5-fluoro- and 6-fluoroindoles are all available from
general chemical suppliers. As a result, we recommend small-
scale expression tests with different fluoroindoles to discover
the optimum labelling strategy. Our results also suggest that
interrogation of a known structure can help identify the
optimum fluoroindole through analysis of close-quarter
atomic interactions.
Ultimately, 19F NMR has provided a useful shift in the NMR
timescales of detection that was a challenge regarding x-linker
observation using 1H, 15N HSQCs. Fluorine NMR enables
direct observation of the tryptophan side chain in b′x and the
19F chemical shift change can be used to study ligand binding
and for identification of the ‘capped’ and ‘uncapped’ confor-
mations of the protein. 19F NMR has also confirmed that the
x-linker is displaced upon binding as the 5-F-Trp chemical
shift tracks from the ‘capped’ to ‘uncapped’ state.
The data provides an excellent fit and a Kd of 23 μM for
Δ-somatostatin binding to 5-F-b′x and this value is marginally
lower than 0.1–1 mM reported for the wild-type protein. We
suggest this was most likely due to destabilisation of ‘capped’
5-F-b′x, stabilisation of protein–peptide complex or a combi-
nation of both factors. Ultimately, this approach can be
expanded further to study multiple PDI domain constructs
and other PDI family members to monitor structure-function
of this isomerase and folding chaperone.
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